The efficacy and safety of Chinese medicines for threatened miscarriage

Miscarriages: Causes, Symptoms and Prevention

Volumn , Issue , 2012, Pages 155-185

  Li, Li ^a   Leung, Ping Chung ^a   Wang, Chi Chiu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869410175     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (99)

1. Loudon I. In: Western Medicine: An Illustrated History. Oxford University Express. Oxford, UK 1997:1-3.
2. Henry LC. In: Chinese natural cures. Publisher New York: Balck Dog & Leventhal Publishers 1994.
3. Wang HH. In: The guideline of Chinese Medicine therapy. Hong Kong. Reader Digest-Yuan Dong Company 2003:34-45.
4. Li JB. In: Zhong Yi Xue. 6th edition. People's Health Publishing House 2005:1-135,186,187.
5. Wang SM, Luo WQ. In: Image of Chinese Medicine: The study on Chinese Medicine history. 1st (ed.) People's Health Publishing House, Bei Jing 2007:1-100.
6. Zmiewski P. In: The Concise pharmacopeia an abridged translation with a systematic method for rendering Chinese medical terms. U.M.I. 1987.
7. Yan ZH. In: Zhong Yao Xue (Chinese Medicines). 2nd ed. Bei Jing. People's Health Publishing House 2006.
8. Chan Z. The State Pharmacopoeia Commission of the People's Republic of China. In: Chinese Pharmacopoeia. 9th (ed.) Chemical Industry Press 2010.
9. Huang KC, Williams WM. In: The Pharmacology of Chinese Herbs. CRC Press 1999:1-14.
10. Xiang YZ, Shang HC, Gao XM, Zhang BL. A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother. Res. 2008; 22:851-858.
11. Radad K, Gille G, Rausch WD. Use of Ginseng in Medicine: Perspectives on CNS Disorders. Iranian Journal of Pharmacology & Therapeutics. 2004;3:30-40.
12. Wang BC, Zhu LC, Chen Q. Primary study on the application of Serum Pharmacology in Chinese traditional medicine. Colloids and Surfaces B-Biointerfaces 2005;43: 194-197.
13. Judith X, Becerra DL, Venable P, Evans H, Bowers WS. Interactions Between Chemical and Mechanical Defenses in the Plant Genus Bursera and Their Implications for Herbivores. Amer. Zool. 2001;41:865-876.
14. Jiang WY. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends in Pharmacological Sciences 2005;26:558-563.
15. Zhang QC, Zhang YL. In: Lyme Disease and Modern Chinese Medicine. Sino-Med. Research Institute 2006.
16. Liu ET. Expression genomics and drug development: Towards predictive pharmacology. Briefings In Functional Genomics and Proteomics. 2005;3:303-321.
17. Strooper BD. Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process. Physiol. Rev. 2010;90:465-494.
18. Feng C. Merging Chinese Traditional Medicine into the American Health System. Journal of Young Investigators. 2002;6:5.
19. Guo P. In: Shan Hai Jing (18 Volumes). 1st ed. Chang. Sha Commercial Press 1939, 1-15.
20. Ma BZ, Liu RF, & Du HL. (2006). In: Zhong Yi Fu Ke Xue. The Science & Technology Press, Shanghai 2006;8:1-200.
21. Zan Y. In: Jing Xiao Chan Bao. Shang Hai Publisher 1995.
22. Chen ZM. In: Jiao Zhu Fu Ren Liang Fang. Hua Xia Publisher 1999:1-100.
23. Zhang CZ. In: Ru Men Shi Qin. Hua Xia Publisher. 1st ed. 1999.
24. Xiao GG. In: Ru Men Shi Qin -Study Report. Chinese Medicine Publisher 1998.
25. Zhou QY, Wu QR. Modified Liu Wei Di Huang Wan for threatened miscarriage. He Nan Medical Journal. 2000;12:58-61.
26. Fu S, Xiao JS. In: Fu Qing Zhu Nv Ke Xin Jie. 1st (ed.) Bei Jing Xue Yuan Publisher 1997.
27. Colmant SA, Eason EA. The Cultural Validity of Complimentary and Alternative Medicine Practices. In: Cultural Validity [On-Line]. Available: www.PsychSymposium.com Accessibility verified 20101231.
28. Chan LY, Chiu PY, Lau TK. An in-vitro study of ginsenoside Rb1-induced teratogenicity using a whole rat embryo culture model. Human Reproduction. 2003;18(10):2166-2168.
29. Hollyer T, Boon H, Georgousis A, Smith M, Einarson A. The use of CAM by women suffering from nausea and vomiting during pregnancy. BMC Comp. Altern. Med. 2002;2:1-6.
30. Holst L, Wright D, Haavik S, Nordeng H. The use and the user of herbal remedies during pregnancy. Altern Comp. Med. 2009;15:787-792.
31. Ong CO, Chan LY, Yung PB, Leung TN. Use of traditional Chinese herbal medicine during pregnancy: a prospective survery. Acta Obstet. Gynecol. Scand. 2005;84: 699-700.
32. Mantani N. Effect of Seihai-to, a Kampo medicine, in relapsing aspiration pneumonia an open-label pilot study. Phytomedicine. 2003;9:195-201.
33. Wang XJ, Shi BZ, Lin GW, Wang Q. A survey on applications of drugs among 416 pregnant women in ShangHai. Chin. J. Pharmacoepid. 1995;4:167-169.
34. Hepner DL, Harnett M, Segal S, Camann W, Bader A, Tsen L. Herbal use in parturients. Anesth. Anal. 2002;94:690-693.
35. Low DT. The use of botanicals during pregnancy and lactation. Altern. Ther. Health Med. 2009;15:54-58.
36. Nordeng H, Havnen G. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepid. Drug Safety. 2004;13:371-380.
37. Della AF, Angela D, Gemma W, Melissa B, Elizabeth M. Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy and Childbirth. 2006;6:21.
38. Chuang CH, Chang PJ, Hsieh WS, Tsai YJ, Lin SJ, Chen PC. Chinese herbal medicines use in in Taiwan during pregnancy and the postpartum period: A population-based cohort study. Int. J. Nurs. Stud. 2009;46:787-795.
39. Hemminki E, Mantyranta T, Malin M, Koponen P. A survey on the use of alternative drugs during pregnancy. Scand. J. Soc. Med. 1991;19:199-204.
40. Gharoro EP, Igbafe AA. Pattern of drug use amongst antenatal patients in Benin City, Nigeria. Med. Sci. Monit. 2000;6:84-87.
41. Gibson PS, Powrie R, Star J. Herbal and alternative medicine use during pregnancy: a cross-sectional survery. Obstet Gynecol 2001;97:S44-S45.
42. Li L. Efficacy and safety of Chinese medicines for pregnancy. Ph.D. Thesis. The Chinese University of Hong Kong, Hong Kong. 2011.
43. Marcus DM, Snodgrass WR. Do no harm: avoidance of herbal medicines during pregnancy. Obstet. Gynecol. 2005;105:1119-1122.
44. Lai YC, Chen YL, Zheng RH. The Cautions and Contraindications of Chinese Herbal Medicine during Pregnancy. Zhong Shan Medical Journal. 2006;17:137-150.
45. Wang JF. In: Database Development and Mechanistic Study of Traditional Chiense Medicine by Computer. (Thesis for Master) National University of Singapore 2003.
46. Zhao LC, Chen F. Food therapy for diarrhea. Journal of the American College of Traditional Chinese Medicine. 1984;1:22-25.
47. D Bensky, R Barolet. In: Chinese Herbal Medicine: Formulas and Strategies. Eastland Press 1990.
48. JL Liu, G Peck. Chinese Dietary Therapy. Churchill Livingstone, London. 1995.
49. Leung PC. Health Aging. Annals of Traditional Chinese Medicine. 2010;4:221-243.
50. Unschuld PU. In: Chinese Medicine. Paradigm Publications. 1998:21-25.
51. Lyttleton J. (2004). In: Treatment of infertility with Chinese medicine. Churchill Livingstone. 2004.
52. Wu K, Chan BQ, Zhang GQ. Toxicity study on Gan Sui. Journal of Medical University of Ha'er Bin. 1990;24(6):484-486.
53. Cunningham FG, Leveno KL, Bloom SL, Hauth JC, Gilstrap LC, Wenstrom KD. Ch. 14. Drugs Commonly Used in Pregnancy. In Teratology, Drugs, and Other Medications. In: Williams Obstetrics. 22nd (Eds.) McGraw-Hill Professional, New York 2005.
54. Loue S, Sajatovic M. In: Encyclopedia of women's health. Springer. 2004.
55. Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ. 1997;315:32-34.
56. Bulletti C, Flamigni C, Giacomucci. Reproductive failure due to spontaneous abortion and recurrent miscarriage. Hum. Reprod. Update. 1996;2:118-136.
57. Orvieto R, Achiron A, Ben-Rafael Z, Achiron R. Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies. Fertil. Steril. 1991: 1013-1020.
58. Brock DJ, Holloway S. Fertility in older women. Lancet 1990;335:1470.
59. Tien JC, Tan TY. Non-surgical interventions for threatened and recurrent miscarriages. Singapore Med. J. 2007;48:1074-1090.
60. Aleman A, Althabe F, Belizan J, Bergel E. Bed rest during pregnancy for preventing miscarriage. Cochrane Database Syst. Rev. 2005;18(2):CD003576.
61. El-Zibdeh MY, Yousef LT. Dydrogesterone support in threatened miscarriage. Maturitas. 2009;65(Suppl 1):S43-46.
62. Devaseelan P, Fogarty PP, Regan L. Human chorionic gonadotrophin for threatened miscarriage. Cochrane Database of Systematic Reviews: Reviews 2010 Issue 5 John Wiley & Sons, Ltd Chichester, UK DOI: 10.1002/14651858.CD007422.pub2.
63. Wahabi HA, Abed ANF, Elawad M, Al-Zeidan RA. Progestogen for treating threatened miscarriage. Cochrane Database of Systematic Reviews: Reviews 2011 Issue 3. John Wiley & Sons, Ltd Chichester, UK. DOI: 10.1002/14651858.CD005943.pub3.
64. Liu RF. Clinical observation of integrated traditional and western medicine. Chin. J. Integr. Trad. West Med. 2002;22:68-69.
65. Bai XM. Pharmacology and clinical application of Bai Zhu. Chinese Medicine Modern Distance Education of China. 2008;6:55-57.
66. Zhang M, Liang GZ, Luo SP. Effect of Zhuyun III on Animal Models with Abortion Induced by Inhibition of Corpus Luteum. Journal of Guangzhou University of Chinese Medicine. 2000;1:589-597.
67. Yao GM. An Tai Yin for recurrent miscarriage. Modern Chinese Medicine. 2003;4, 138-140.
68. Chou HG. Clinical observation on 112 cases of abortion treated by supplemented shoutai wuzi soup. J. Youjiang Med. College Nationalities. 2002:301-302.
69. Zhou SP. An Dian Er Tian Decoction for recurrent miscarriage. Journal of Medical Forum. 2008;05:1135-1138.
70. Liu HX, Zhang YL, Yang KM. The clinical application of Jiao Ai Decoction. Journal of He Nan Chinese Medicine. 1998;1:55-57.
71. Liu MX. Clinical Observation on 40 Cases of Threatened Abortion Treated by Supplemented Shoutai Pill. Clinical Journal of Anhui Traditional Chinese Medicne. 2002;14(2),123.
72. Li L, Wang CC, Dou L, Leung PC. In: Chinese herbal medicines for threatened miscarriage: review. Cochrane Database Syst. Rev. 2011 [In Press].
73. Westfall RE. Herbal medicine in pregnancy and childbirth. Adv. Ther. 2001;18:47-55.
74. Cochrane Review 2010. In: Cochrane reviews of complementary and alternative therapies: evaluating the strength of the evidence. Cochrane Collaboration. Published 2004. Accessed 9 January 2010.
75. Chen JH. 51 Cases of threatened abortion treated by combined medicines. Ningxia Med. J. 2002;8:506.
76. Feng ZR. Combined Chinese and Westen medicines for threatened miscarriage. Journal of Jiang Shu Chinese Medicine. 1997;9(18):23.
77. Lv XH, Han YP, LuoY. Observation on 58 cases of threatened miscarriage. Journal of Yun Nan Chinese Medicine. 2007;28(12):11.
78. Zhong DM, Jiang HZ. Jian Pi Gu Shen formula for threatened miscarriage-90 cases. Research of Chinese Medicine. 2002;15(4):24-26.
79. Long T. Clinical Observation on 61 Cases of Miscarriage Treated by Supplemented Shoutai Pill. Gansu Journal of Traditional Chinese Medicine. 1994;7(2):55-56.
80. Zhou J. Clinical Application of Shoutai Pill and Sijunzi Soup on Miscarriage. Chinese Medicine and Materia Medica. 1993;3:42.
81. Xu L. Shou Tai Pill as treatment to abortion. Journal of Guiyang College of Traditional Chinese Medicine. 2002;1:59-70.
82. Wang Y. Clinical Observation on 122 Cases of Threatened Abortion Treated by Supplemented Shoutai Pill. Journal of Traditional Chinese Medicine and Chinese Materia Medica of Jilin. 1990;6:24.
83. Times 1937. "Wallace Reveals How Federal Agents Traced Elixir to Halt Fatalities". New York, US. Times. November 26, 1937.
84. http://select.nytimes.com/gst/abstract.html?res=F40C15F93B59177A93C4AB178AD95F438385F9. Retrieved 2009-07-20. " A graphic story of a race against death from " elixir sulfanilamide," carried on by the Food and Drug Administration in fifteen States from Virginia to California, a race not won until ninety-three persons had died after taking the lethal dose, was told by Secretary Wallace today in a report responding to Senate and House resolutions."
85. FDA 1981. Taste of Raspberries, Taste of Death. The 1937 Elixir Sulfanilamide Incident, FDA Consumer magazine.
86. Burkholz H. "Giving Thalidomide a Second Chance". FDA Consumer (US Food and Drug Administration). Consumer magazine June 1981.
87. Cunningham FG, Leveno KL, Bloom SL, Hauth JC, Gilstrap LC, Wenstrom KD. In: Williams Obstetrics. 22nd (Eds.) McGraw-Hill Professional, New York 2005:231-241.
88. Genschow E, Spielmann H, Scholz G, Seiler A, Brown N, Piersma A, Brady M, Clemann N, Huuskonen H, Paillard F, Bremer S, Becker K. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods. Altern. Lab. Anim. 2002;30:151-176.
89. Song YL, Zhu LP. The fetus protection of Zhixue Baotai decoction on women of early threatened abortion with dark area surrounding pregnancy sac. Chin. J. Integ. Trad. West Med. 2007;27:1025-1028.
90. Gu YT, Zhang GR, Gong G. 35 cases of Le Yun Ning decoction for threatened miscarriage. Qiqihar Med. College. 2008;29:433.
91. Chen Q, Zhao RL, Ma YY, Guo YY, Hu YF, Weng XY, Gai MY, Huang XH, Zhou LH, Liu WJ, Zhao TW. 231 clinical observations on Zishen Yutai pill for threatened miscarriages. Chin. J. Perinat. Med. 2001;4:85.
92. Luo HT, Zhao SP, Yuan HX. 58 cases of ultrasound observations on threatened abortions with PPS. J. Shaanxi College Trad. Chin. Med. 2007;30:26.
93. Zhou Y. Qinical Observation on Shoutai Pill and Shixiao Powder for the Treatment of Threatened Abortion with Kidney Deficiency and Blood Stasis. Journal of Guangzhou University of Traditional Chinese Medicine. 2006;23(01):25-29.
94. Cui SH. Treatment on 47 cases of abortion. Shanxi J. Trad. Chin. Med. 1998;19:242.
95. Zhou Y. Clinical Observation on 305 Cases of Threatened Abortion Treated by Integrated Traditional Chinese and Western Medicine. The P ractical. Journal of Integrating Chinese with Modern Medicine 1997;10(16):1614.
96. Wu ZG. Clinical observation on 41 cases of threatened abortion treated by shoutai pill the addition and subtraction. Central Plains Med. J. 1987;3:3-9.
97. Li L, Tang LY, Man GCW, Yeung HK, Lau BS, Leung PC, Wang CC. Potential reproductive toxicity of Largehead Atractylodes Rhizome, the most commonly used Chinese medicine for threatened miscarriage. Hum. Reprod. 2011;26:3280-3288.
98. Zheng XY, National phamacopoeia committee. In: Chinese Pharmacopeia. 8th (ed.) Chemical Industry Publishing House. 2005.
99. Scheid V. In: Chinese Medicine in Contemporary China: Plurality and Synthesis. Duke University Press, Durham, North Carolina, US 2002.